South San Francisco, CA — December 21, 2022 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab)…Original Article
FDA Approves Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults
